Talk:ApoB

This paragraph (which was a section titled -Drugs Acting on ApoB-) reads like an ad to me. Appropriate? RJFJR 06:08, 17 February 2006 (UTC)
 * Isis Pharmaceuticals is currently working on a drug tenatively named 301012, which causes dose-dependent, rapid and prolonged reductions of apoB-100. The company claims it can decrease levels of LDL and VLDL by 55%. Functionally, the drug reduces ApoB levels via antisense technology. This drug is different from the statin drugs currently on the market.